AU2009245322B2 - Novel class of spiro piperidines for the treatment of neurodegenerative diseases - Google Patents
Novel class of spiro piperidines for the treatment of neurodegenerative diseases Download PDFInfo
- Publication number
- AU2009245322B2 AU2009245322B2 AU2009245322A AU2009245322A AU2009245322B2 AU 2009245322 B2 AU2009245322 B2 AU 2009245322B2 AU 2009245322 A AU2009245322 A AU 2009245322A AU 2009245322 A AU2009245322 A AU 2009245322A AU 2009245322 B2 AU2009245322 B2 AU 2009245322B2
- Authority
- AU
- Australia
- Prior art keywords
- methyl
- thia
- triazaspiro
- fluorophenyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5042308P | 2008-05-05 | 2008-05-05 | |
| US61/050,423 | 2008-05-05 | ||
| PCT/IB2009/051815 WO2009136350A1 (en) | 2008-05-05 | 2009-05-04 | Novel class of spiro piperidines for the treatment of neurodegenerative diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2009245322A1 AU2009245322A1 (en) | 2009-11-12 |
| AU2009245322B2 true AU2009245322B2 (en) | 2011-07-14 |
Family
ID=40902870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009245322A Ceased AU2009245322B2 (en) | 2008-05-05 | 2009-05-04 | Novel class of spiro piperidines for the treatment of neurodegenerative diseases |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20110046160A1 (https=) |
| EP (1) | EP2300484B1 (https=) |
| JP (1) | JP2011519913A (https=) |
| KR (1) | KR20110000749A (https=) |
| CN (1) | CN102083841A (https=) |
| AP (1) | AP2010005456A0 (https=) |
| AT (1) | ATE537178T1 (https=) |
| AU (1) | AU2009245322B2 (https=) |
| BR (1) | BRPI0912433A2 (https=) |
| CA (1) | CA2721786A1 (https=) |
| CO (1) | CO6321280A2 (https=) |
| CR (1) | CR11759A (https=) |
| DO (1) | DOP2010000317A (https=) |
| EA (1) | EA201001566A1 (https=) |
| EC (1) | ECSP10010597A (https=) |
| ES (1) | ES2375913T3 (https=) |
| IL (1) | IL208793A0 (https=) |
| MA (1) | MA32290B1 (https=) |
| MX (1) | MX2010012066A (https=) |
| NZ (1) | NZ588589A (https=) |
| SV (1) | SV2010003725A (https=) |
| WO (1) | WO2009136350A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| EP2556076A2 (en) * | 2010-04-09 | 2013-02-13 | Pfizer Inc. | Novel sultam compounds |
| EP2694489B1 (en) | 2011-04-07 | 2017-09-06 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| EP2694521B1 (en) | 2011-04-07 | 2015-11-25 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| RU2014111055A (ru) | 2011-08-22 | 2015-09-27 | Мерк Шарп И Доум Корп. | 2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение |
| US10752588B2 (en) | 2014-12-19 | 2020-08-25 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
| WO2016100940A1 (en) | 2014-12-19 | 2016-06-23 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006044497A2 (en) * | 2004-10-13 | 2006-04-27 | Merck & Co., Inc. | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease |
| WO2007011810A1 (en) * | 2005-07-18 | 2007-01-25 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| WO2008030412A2 (en) * | 2006-09-07 | 2008-03-13 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004031560D1 (de) * | 2004-01-08 | 2011-04-07 | Hoffmann La Roche | Diazaspiropiperidinderivate |
| JP2006044497A (ja) * | 2004-08-05 | 2006-02-16 | Toyota Motor Corp | 車輪情報処理装置 |
| AU2007342368A1 (en) * | 2007-01-04 | 2008-07-17 | Merck & Co., Inc. | Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
-
2009
- 2009-05-04 US US12/990,739 patent/US20110046160A1/en not_active Abandoned
- 2009-05-04 KR KR1020107024794A patent/KR20110000749A/ko not_active Ceased
- 2009-05-04 WO PCT/IB2009/051815 patent/WO2009136350A1/en not_active Ceased
- 2009-05-04 ES ES09742523T patent/ES2375913T3/es active Active
- 2009-05-04 CA CA2721786A patent/CA2721786A1/en not_active Abandoned
- 2009-05-04 EA EA201001566A patent/EA201001566A1/ru unknown
- 2009-05-04 AT AT09742523T patent/ATE537178T1/de active
- 2009-05-04 EP EP09742523A patent/EP2300484B1/en active Active
- 2009-05-04 AU AU2009245322A patent/AU2009245322B2/en not_active Ceased
- 2009-05-04 JP JP2011508035A patent/JP2011519913A/ja not_active Withdrawn
- 2009-05-04 NZ NZ588589A patent/NZ588589A/en not_active IP Right Cessation
- 2009-05-04 BR BRPI0912433A patent/BRPI0912433A2/pt not_active Application Discontinuation
- 2009-05-04 CN CN2009801261947A patent/CN102083841A/zh active Pending
- 2009-05-04 MX MX2010012066A patent/MX2010012066A/es not_active Application Discontinuation
- 2009-05-04 AP AP2010005456A patent/AP2010005456A0/xx unknown
-
2010
- 2010-10-18 IL IL208793A patent/IL208793A0/en unknown
- 2010-10-21 DO DO2010000317A patent/DOP2010000317A/es unknown
- 2010-10-26 CR CR11759A patent/CR11759A/es not_active Application Discontinuation
- 2010-11-05 SV SV2010003725A patent/SV2010003725A/es not_active Application Discontinuation
- 2010-11-05 MA MA33328A patent/MA32290B1/fr unknown
- 2010-11-09 EC EC2010010597A patent/ECSP10010597A/es unknown
- 2010-11-11 CO CO10141834A patent/CO6321280A2/es not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006044497A2 (en) * | 2004-10-13 | 2006-04-27 | Merck & Co., Inc. | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease |
| WO2007011810A1 (en) * | 2005-07-18 | 2007-01-25 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| WO2008030412A2 (en) * | 2006-09-07 | 2008-03-13 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0912433A2 (pt) | 2015-12-22 |
| EA201001566A1 (ru) | 2011-04-29 |
| CO6321280A2 (es) | 2011-09-20 |
| EP2300484A1 (en) | 2011-03-30 |
| CR11759A (es) | 2010-11-22 |
| ES2375913T3 (es) | 2012-03-07 |
| ATE537178T1 (de) | 2011-12-15 |
| US20110046160A1 (en) | 2011-02-24 |
| JP2011519913A (ja) | 2011-07-14 |
| MA32290B1 (fr) | 2011-05-02 |
| SV2010003725A (es) | 2011-07-05 |
| KR20110000749A (ko) | 2011-01-05 |
| DOP2010000317A (es) | 2010-11-15 |
| AU2009245322A1 (en) | 2009-11-12 |
| AP2010005456A0 (en) | 2010-12-31 |
| WO2009136350A1 (en) | 2009-11-12 |
| CA2721786A1 (en) | 2009-11-12 |
| IL208793A0 (en) | 2010-12-30 |
| CN102083841A (zh) | 2011-06-01 |
| NZ588589A (en) | 2012-07-27 |
| ECSP10010597A (es) | 2010-12-30 |
| MX2010012066A (es) | 2010-12-06 |
| EP2300484B1 (en) | 2011-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009245322B2 (en) | Novel class of spiro piperidines for the treatment of neurodegenerative diseases | |
| JP4932065B2 (ja) | βセクレターゼ阻害剤としてのラクタム | |
| AU2010311035B2 (en) | Imidazole derivatives as casein kinase inhibitors | |
| US20120053165A1 (en) | Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators | |
| US20080312271A1 (en) | Azabenzimidazolyl compounds | |
| WO2011048525A1 (en) | Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators | |
| US20130150376A1 (en) | Novel Sultam Compounds | |
| US20120295923A1 (en) | Aminocyclohexanes and Aminotetrahydropyrans and Related Compounds As Gamma-Secretase Modulators | |
| CA3237171A1 (en) | Dioxazines and their use in treatment of gba-related diseases | |
| HK1153457A (zh) | 用於治疗神经变性疾病的新型螺哌啶类化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |